One Wall Street analyst thinks Nio will see record quarterly sequential growth. New EV offerings could help the stock surge, ...

Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for ...

Our free stock report includes 1 warning sign investors should be aware of before investing in Catalyst Bancorp ... Alternatively, email editorial-team (at) simplywallst.com.

Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Catalyst Pharmaceuticals (NASDAQ:CPRX).